Stephen Holgate
University of Southampton
H-index: 186
Europe-United Kingdom
Top articles of Stephen Holgate
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The impact of outdoor pollution and extreme temperatures on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases … | Ioana Agache Carlos Canelo‐Aybar Isabella Annesi‐Maesano Lorenzo Cecchi David Rigau | 2024/2/4 | |
EAACI guidelines on environmental science for allergy and asthma: The impact of short‐term exposure to outdoor air pollutants on asthma‐related outcomes and recommendations for … | Allergy | Ioana Agache Isabella Annesi‐Maesano Lorenzo Cecchi Benedetta Biagioni Kian Fan Chung | 2024/4/2 |
Letter from the UK: Reflections on a turbulent 5 years | Respirology | Stephen T Holgate | 2024/1/23 |
The impact of indoor pollution on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma | Ioana Agache Carlos Canelo‐Aybar Isabella Annesi‐Maesano Lorenzo Cecchi Benedetta Biagioni | 2024/2/17 | |
The lived experience of immune-mediated noncommunicable diseases in relation to environmental change | Stephen T Holgate | 2024/4/4 | |
Clinical Development of Inhaled Interferon Beta-1a (SNG001) for the Treatment of Patients With COVID-19 in the Home and Hospital Settings | PD Monk J Brookes V Tear T Batten M Mankowski | 2023/5 | |
Clinical trials of inhaled interferon beta-1a (SNG001) in COVID-19 patients in the home and hospital | Phillip D Monk Jody Brookes Victoria Tear Toby Batten Marcin Mankowski | 2023/9/9 | |
In memoriam: Lawrence M. Lichtenstein (1934–2022). | Allergy | Gianni Marone Massimo Triggiani Vincenzo Casolaro Cristiana Stellato Amato de Paulis | 2023/1/1 |
Air pollution and climate change | Global Health Leadership: Case Studies From the Asia-Pacific | Jonathan Samet Alistair Woodward | 2019 |
Nebulised interferon-Β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study | ERJ open research | Phillip D Monk Jody L Brookes Victoria J Tear Toby N Batten Marcin Mankowski | 2023/3/1 |
Celebrating 75 years of BSACI | Pamela W Ewan Stephen R Durham Glenis K Scadding Stephen T Holgate | 2023/12 | |
Is exposure to pollen a risk factor for moderate and severe asthma exacerbations? | Isabella Annesi‐Maesano Lorenzo Cecchi Benedetta Biagioni Kian Fan Chung Bernard Clot | 2023/8 | |
375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease … | Open Forum Infectious Diseases | Phillip D Monk Jody L Brookes Victoria J Tear Toby Batten Clare Newall | 2023/12 |
Responses from Stephen Houlgate | Hegel Bulletin | Stephen Houlgate | 2023 |
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper | Allergy | Marek Jutel Ioana Agache Magdalena Zemelka‐Wiacek Mübeccel Akdis Tomás Chivato | 2023/11 |
Air pollution is a public health emergency | Stephen Holgate | 2022/7/11 | |
Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial | Open Forum Infectious Diseases | PD Monk RA Evans VJ Tear JL Brookes T Batten | 2022 |
LB1533. Impact of Treatment of Hospitalised COVID-19 Patients With Inhaled Interferon Beta-1a (SNG001) on Long COVID Symptoms: Results From the SPRINTER trial | Open Forum Infectious Diseases | Phillip D Monk Rachael A Evans Victoria J Tear Jody L Brookes Toby Batten | 2022/12/1 |
SPRINTER: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Determine the Efficacy and Safety of Inhaled Interferon Beta-1a (SNG001) for the Treatment of … | Phillip D Monk Jody Brookes Victoria Tear Toby Batten Marcin Mankowski | 2022/9/4 | |
Respiratory research in the UK: investing for the next 10 years | Thorax | Ian Hall Samantha Walker Stephen T Holgate | 2022/9/1 |
